| A review of potential suggested drugs for coronavirus disease (COVID-19) treatment P Tarighi, S Eftekhari, M Chizari, M Sabernavaei, D Jafari, P Mirzabeigi European Journal of Pharmacology 895, 173890, 2021 | 143 | 2021 |
| The benefits of folic acid-modified gold nanoparticles in CT-based molecular imaging: radiation dose reduction and image contrast enhancement J Beik, M Jafariyan, A Montazerabadi, A Ghadimi-Daresajini, P Tarighi, ... Artificial cells, nanomedicine, and biotechnology 46 (8), 1993-2001, 2018 | 63 | 2018 |
| Thiolated chitosan-lauric acid as a new chitosan derivative: Synthesis, characterization and cytotoxicity MS Kazemi, Z Mohammadi, M Amini, M Yousefi, P Tarighi, S Eftekhari, ... International journal of biological macromolecules 136, 823-830, 2019 | 48 | 2019 |
| The relationship between molecular content of mesenchymal stem cells derived exosomes and their potentials: opening the way for exosomes based therapeutics D Jafari, S Malih, SS Eslami, R Jafari, L Darzi, P Tarighi, ... Biochimie 165, 76-89, 2019 | 42 | 2019 |
| Formulation development and toxicity assessment of triacetin mediated nanoemulsions as novel delivery systems for rapamycin H Sobhani, P Tarighi, SN Ostad, A Shafaati, N Nafissi-Varcheh, ... Iranian journal of pharmaceutical research: IJPR 14 (Suppl), 3, 2015 | 41 | 2015 |
| Combination of curcumin and metformin inhibits cell growth and induces apoptosis without affecting the cell cycle in LNCaP prostate cancer cell line SS Eslami, D Jafari, H Montazeri, M Sadeghizadeh, P Tarighi Nutrition and Cancer 73 (6), 1026-1039, 2021 | 26 | 2021 |
| CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations MM Gomari, M Farsimadan, N Rostami, M Fadaie, I Farhani, P Tarighi Mutation Research/Reviews in Mutation Research 787, 108374, 2021 | 25 | 2021 |
| Synergistic anti-tumor effects of Liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line S Eftekhari, H Montazeri, P Tarighi European Journal of Pharmacology 878, 173102, 2020 | 23 | 2020 |
| Evaluation of antimicrobial effectiveness of ophthalmic drops according to the pharmacopeial tests criteria N Samadi, P Tarighi, MR Fazeli, H Mehrgan DARU JOURNAL OF PHARMACEUTICAL SCIENCE 17 (1), 13-18, 2009 | 16 | 2009 |
| Growth promotion and increased ATP-binding cassette transporters expression by liraglutide in triple negative breast cancer cell line MDA-MB-231 A Shadboorestan, P Tarighi, M Koosha, H Faghihi, MH Ghahremani, ... Drug Research 71 (06), 307-311, 2021 | 10 | 2021 |
| Synergistic cytotoxic and apoptotic effects of local probiotic Lactobacillus brevis isolated from regional dairy products in combination with tamoxifen Z Nasiri, H Montazeri, N Akbari, SS Mirfazli, P Tarighi Nutrition and Cancer 73 (2), 290-299, 2021 | 9 | 2021 |
| Preparation of diphtheria and pseudomonas exotoxin a immunotoxins and evaluation of their cytotoxicity effect on SK-BR-3, BT-474, and MDA-MB-231 breast cancer cell lines S Amoozadeh, M Hemmati, MM Farajollahi, N Akbari, P Tarighi Cancer investigation 37 (10), 546-557, 2019 | 9 | 2019 |
| uPAR peptide antagonist alters regulation of MAP kinases and Bcl-2 family members in favor of apoptosis in MDA-MB-231 cell line P Tarighi, H Montazeri, MR Khorramizadeh, SN Ostad, MH Ghahremani Research in Pharmaceutical Sciences 10 (3), 200-205, 2015 | 9 | 2015 |
| Structural evolution of Delta lineage of SARS-CoV-2 MM Gomari, P Tarighi, E Choupani, S Abkhiz, M Mohamadzadeh, ... International journal of biological macromolecules 226, 1116-1140, 2023 | 8 | 2023 |
| Implementation of docking, molecular dynamics and free energy to investigate drug potency of novel BCR-ABLT315I inhibitors as an alternative to ponatinib MM Gomari, N Rostami, A Ghodrati, Y Hernandez, M Fadaie, SS Eslami, ... Computational Toxicology 20, 100180, 2021 | 8 | 2021 |
| Effects of sitagliptin as monotherapy and add-on to metformin on weight loss among overweight and obese patients with type 2 diabetes: A systematic review and meta-analysis L Janani, H Bamehr, K Tanha, P Mirzabeigi, H Montazeri, P Tarighi Drug Research 71 (09), 477-488, 2021 | 8 | 2021 |
| Rapamycin-Loaded, CapryolTM 90 and Oleic Acid Mediated Nanoemulsions: Formulation Development, Characterization and Toxicity Assessment H Sobhani, P Tarighi, SN Ostad, A Shafaati, N Nafissi-Varcheh, ... Iranian Journal of Pharmaceutical Research: IJPR 17 (3), 830, 2018 | 8 | 2018 |
| Production and conjugation of truncated recombinant diphtheria toxin to VEGFR-2 specific nanobody and evaluation of its cytotoxic effect on PC-3 cell line S Shajari, MM Farajollahi, M Behdani, P Tarighi Molecular Biotechnology 64 (11), 1218-1226, 2022 | 5 | 2022 |
| A review of therapeutic antibodies in breast cancer M Eini, N Zainodini, H Montazeri, P Mirzabeigi, P Tarighi Journal of Pharmacy & Pharmaceutical Sciences 24, 363-380, 2021 | 5 | 2021 |
| Growth inhibition of MDA-MB-231 cell line by peptides designed based on uPA P Tarighi, MR Khorramizadeh, AM Sobhani, SN Ostad, MH Ghahremani Acta Medica Iranica, 403-407, 2015 | 5 | 2015 |
